After hours
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Sale
Calculated transaction value
$285.04K

Rothblatt Martine A Chairperson & CEO

Transaction date Nov 4, 2026
Public filing date Nov 5, 2026
Filing lag Filed 1 day later

UTHR daily price context

Close on/before transaction
$608.49 Nov 4, 2026
First close after public filing
$562.02 Nov 6, 2026
Return after filing · so far
+5.99% Through Nov 11, 2026

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Common Stock
Quantity / price
477 shares @ $597.56
SEC ownership
Indirect
Transaction code
S
Form
4
Filing identifier
0001106578-26-000179
Filing cohort

Transactions in this filing

Showing 15 of 26
Trades
26
Issuers
1
Estimated value
$5.78M
Buys / sales
0 / 24
Transactions reported in the same official filing
Issuer Transaction Traded Value
United Therapeutics Corp UTHR Sale Nov 4, 2026 $22.65K
United Therapeutics Corp UTHR Sale Nov 4, 2026 $46.73K
United Therapeutics Corp UTHR Sale Nov 4, 2026 $758.32K
United Therapeutics Corp UTHR Sale Nov 4, 2026 $360.58K
United Therapeutics Corp UTHR Sale Nov 4, 2026 $321.29K
United Therapeutics Corp UTHR Sale Nov 4, 2026 $126.74K
United Therapeutics Corp UTHR Sale Nov 4, 2026 $77.43K
United Therapeutics Corp UTHR Sale Nov 4, 2026 $95.14K
United Therapeutics Corp UTHR Current Sale Nov 4, 2026 $285.04K
United Therapeutics Corp UTHR Sale Nov 4, 2026 $163.97K
United Therapeutics Corp UTHR Sale Nov 4, 2026 $235.28K
United Therapeutics Corp UTHR Sale Nov 4, 2026 $190.79K
United Therapeutics Corp UTHR Sale Nov 4, 2026 $96.56K
United Therapeutics Corp UTHR Exercise Nov 4, 2026 $0
United Therapeutics Corp UTHR Sale Nov 4, 2026 $109.64K